Vivek Asati

发表

PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives.

Debarshi Kar Mahapatra, Sanjay Kumar Bharti, Vivek Asati, 2016, European journal of medicinal chemistry.

Thiazolidine‐2,4‐diones as Multi‐targeted Scaffold in Medicinal Chemistry: Potential Anticancer Agents

Vivek Asati, D. Mahapatra, S. Bharti, 2015 .

SWFB and GA Strategies for Variable Selection in QSAR Studies for the Validation of Thiazolidine- 2,4-Dione Derivatives as Promising Antitumor Candidates

Vivek Asati, D. Mahapatra, S. Bharti, 2017 .

Design, synthesis and molecular modeling studies of novel thiazolidine-2,4-dione derivatives as potential anti-cancer agents

Vivek Asati, S. Bharti, 2018 .

In-silico studies for the development of novel RET inhibitors for cancer treatment

Vivek Asati, Abuzer Ali, Amena Ali, 2021, Journal of Molecular Structure.

Molecular modeling studies of some thiazolidine-2,4-dione derivatives as 15-PGDH inhibitors

S. Bajaj, Vivek Asati, D. Mahapatra, 2015, Medicinal Chemistry Research.

Structural aspects of triazole derivatives as HSP90 inhibitors for the treatment of cancer: in silico studies

Vivek Asati, Abuzer Ali, Amena Ali, 2022, Journal of biomolecular structure & dynamics.

PIM kinase inhibitors: Structural and pharmacological perspectives.

Debarshi Kar Mahapatra, Vivek Asati, D. Mahapatra, 2019, European journal of medicinal chemistry.

An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent.

Vivek Asati, S. Kashaw, Shivangi Agarwal, 2020, European journal of medicinal chemistry.

3D-QSAR and virtual screening studies of thiazolidine-2,4-dione analogs: Validation of experimental inhibitory potencies towards PIM-1 kinase

Vivek Asati, S. Bharti, A. Budhwani, 2017 .

ISSN: 2249-0337 Original Article Antidiabetic effect of a compound ethanolic extract of Annona squamosa, Eclipta alba, Butea monosperma in experimental animals

Vivek Asati, Nitin Dwivedi, Asati Vivek, 2012 .

In silico study for the identification of potential compounds as PIM-1 kinase inhibitors

Vivek Asati, Shah Ayaz, 2022, Pharmaspire.

Quality by design assisted high‐performance liquid chromatography parameters for simultaneous estimation of simvastatin and fenofibrate

Vivek Asati, Dilpreet K Singh, P. Patel, 2022, SEPARATION SCIENCE PLUS.

An Investigative Review for Pharmaceutical Analysis of Fenofibrate.

Vivek Asati, Moumita Saha, G. Gupta, 2022, Journal of chromatographic science.

Design, Synthesis and Molecular Modeling Studies of Thiosemicarbazone & Thiazole Derivatives as Potential Anti-Malarial Agents

Vivek Asati, K. Kaur, 2021 .

3D-QSAR and molecular docking studies on oxadiazole substituted benzimidazole derivatives: Validation of experimental inhibitory potencies towards COX-2.

S. Bajaj, P. Ghode, S. Jain, 2018, Current computer-aided drug design.

GnRH Analogs As Modulator of LH and FSH: Exploring Clinical Importance

Vivek Asati, D. Mahapatra, S. Bharti, 2015 .

Synthesis, characterization and antimicrobial evaluation of some 1,3-benzothiazole-2-yl-hydrazone derivatives

Vivek Asati, N. Sahu, D. Kohli, 2015 .

1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents.

S. Bajaj, Jagadish Singh, P. Roy, 2015, European journal of medicinal chemistry.

Recent development of piperazine and piperidine derivatives as antipsychotic agents.

Vivek Asati, S. Kashaw, Shivangi Agarwal, 2020, Mini-Reviews in Medical Chemistry.

Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives.

Vivek Asati, D. Mahapatra, S. Bharti, 2015, European journal of medicinal chemistry.

Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological perspectives.

Debarshi Kar Mahapatra, Vivek Asati, D. Mahapatra, 2015, European journal of medicinal chemistry.

Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.

Debarshi Kar Mahapatra, Vivek Asati, D. Mahapatra, 2019, European journal of medicinal chemistry.

Anti-cancer chalcones: Structural and molecular target perspectives.

Vivek Asati, D. Mahapatra, S. Bharti, 2015, European journal of medicinal chemistry.

Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents.

Debarshi Kar Mahapatra, Vivek Asati, D. Mahapatra, 2014, European journal of medicinal chemistry.

1,3,4‐Oxadiazoles: An Emerging Scaffold to Target Growth Factors, Enzymes and Kinases as Anticancer Agents

S. Bajaj, Jagadish Singh, P. Roy, 2015 .

Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives.

Vivek Asati, D. Mahapatra, S. Bharti, 2017, Current topics in medicinal chemistry.

TARGETING CANCER CELLS: A NEW THERAPY TO CURE CANCER PATIENTS

Vivek Asati, J. Rathi, K. Patel, 2019 .

Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches.

Vivek Asati, K. Kaur, P. Patel, 2021, European journal of medicinal chemistry.

K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives.

Debarshi Kar Mahapatra, Vivek Asati, D. Mahapatra, 2017, European journal of medicinal chemistry.

Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives.

Debarshi Kar Mahapatra, Vivek Asati, D. Mahapatra, 2015, European journal of medicinal chemistry.

An analytical review for the estimation of montelukast sodium

Vivek Asati, M. Saha, G. Gupta, 2022, SEPARATION SCIENCE PLUS.

Computational screening for the identification of potent tubulin inhibitors as anticancer agents

Vivek Asati, Priyanka Sharma, 2022, Pharmaspire.

MEK inhibitors in oncology: a patent review (2015-Present)

Debarshi Kar Mahapatra, Vivek Asati, D. Mahapatra, 2017, Expert opinion on therapeutic patents.

Virtual Screening, Molecular Docking, and DFT Studies of Some Thiazolidine‐2,4‐diones as Potential PIM‐1 Kinase Inhibitors

Vivek Asati, S. Bharti, S. S. Thakur, 2018 .

QSAR studies for some thiazolidine-2,4-dione derivatives as PIM-2 kinase inhibitors

Vivek Asati, S. Bharti, 2016, Medicinal Chemistry Research.

Structural prediction of novel pyrazolo-pyrimidine derivatives against PIM-1 kinase: In-silico drug design studies

Vivek Asati, S. Kashaw, Shivangi Agarwal, 2020 .

RECENT THERAPEUTIC PROGRESS OF CHALCONE SCAFFOLD BEARING COMPOUNDS AS PROSPECTIVE ANTI-GOUT CANDIDATES

Vivek Asati, D. Mahapatra, S. Bharti, 2019, Journal of Critical Reviews.

Reversed‐phase high‐performance liquid chromatography analytical method development and validation for cefepime and sulbactam injection formulation assay: A quality by design approach

Vivek Asati, G. Gupta, B. Kurmi, 2023, SEPARATION SCIENCE PLUS.

Analytical reversed‐phase high‐performance layer chromatography method development for silodosin and solifenacin in bulk and marketed formulation using analytical quality by design approach

Vivek Asati, B. Kurmi, Shubham Dhiman, 2022, SEPARATION SCIENCE PLUS.

Identification of potential N-substituted 5-benzylidenethiazolidine-2,4-dione derivatives as α-amylase inhibitors: computational cum synthetic studies

Vivek Asati, G. Gupta, Shankareswar Gupta, 2023, Journal of Molecular Structure.

Field and atom-based 3D-QSAR models of chromone (1-benzopyran-4-one) derivatives as MAO inhibitors

Vivek Asati, Abuzer Ali, Amena Ali, 2023, Journal of biomolecular structure & dynamics.

Integrated computational approach on sodium-glucose co-transporter 2 (SGLT2) Inhibitors for the development of novel antidiabetic agents

Vivek Asati, S. Kashaw, Varsha Kashaw, 2020 .

Anti-cancer chalcones: Structural and molecular target perspectives.

Debarshi Kar Mahapatra, Vivek Asati, D. Mahapatra, 2015, European journal of medicinal chemistry.

Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach

Vivek Asati, B. Kumar, Preeti Patel, 2023, Molecular diversity.

In silico studies for the identification of potential thiazolidine-2,4-diones as α-amylase inhibitors

Vivek Asati, K. Dagar, Shankareswar Gupta, 2023, Pharmaspire.

Anti-Inflammatory activity of seeds extract of datura stramonium against carrageenan induced paw edema on albino wistar rats

Vivek Asati, J. Rathi, R. Gupta, 2019, Journal of Pharmaceutical and Biological Sciences.

Current insights into the chemistry and antitubercular potential of benzimidazole and imidazole derivatives.

Vivek Asati, S. Kashaw, Shivangi Agarwal, 2020, Mini reviews in medicinal chemistry.

Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.

Vivek Asati, G. Gupta, Ritu, 2023, Bioorganic chemistry.

Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia

Vivek Asati, S. Kashaw, Varsha Kashaw, 2022, In silico pharmacology.

A Computational approach to discover potential quinazoline derivatives against CDK4/6 kinase

Vivek Asati, Abuzer Ali, Amena Ali, 2021 .

Discovery of novel ALK2 inhibitors of pyrazolo-pyrimidines: A computational study

Vivek Asati, S. Bharti, S. Kashaw, 2021, Journal of biomolecular structure & dynamics.

Recent Progress in Histone deacetylase (HDAC) 1 Inhibitors as Anticancer Agent.

Vivek Asati, H. Rajak, P. Patel, 2022, Current cancer drug targets.

Inhibition performances of new pyrazole derivatives against the corrosion of C38 steel in acidic medium: Computational study

Vivek Asati, D. Ö. Işın, Savas Kaya, 2024, Results in Surfaces and Interfaces.

Structural Aspects of mTOR Inhibitors: In Progress to Search Potential Compounds.

Vivek Asati, K. Kaur, Arjun Anant, 2021, Anti-cancer agents in medicinal chemistry.

A comprehensive review of small molecules targeting PI3K pathway: Exploring the structural development for the treatment of breast cancer.

Vivek Asati, G. Gupta, Rahul Dubey, 2023, Bioorganic chemistry.

Formulation and evaluation of sustain released matrix tablet of atenolol

Vivek Asati, J. Rathi, S. Sahu, 2019, Journal of Drug Delivery and Therapeutics.

FURAN AND BENZOFURAN DERIVATIVES AS PRIVILEGED SCAFFOLDS AS ANTICANCER AGENTS: SAR AND DOCKING STUDIES (2010 to till date)

Vivek Asati, H. Rajak, B. Kurmi, 2023, Journal of Molecular Structure.

PIM kinase inhibitors: an updated patent review (2016-present)

Debarshi Kar Mahapatra, Vivek Asati, S. Bharti, 2024, Expert opinion on therapeutic patents.

Promising Anticancer Potentials of Natural Chalcones as Inhibitors of Angiogenesis

Debarshi Kar Mahapatra, Vivek Asati, S. Bharti, 2020 .

Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies.

Debarshi Kar Mahapatra, Vivek Asati, S. Bharti, 2016, Current pharmaceutical design.

An updated patent review of therapeutic applications of chalcone derivatives (2014-present)

Vivek Asati, S. Bharti, Debarshi Kar Mahapatra, 2019, Expert opinion on therapeutic patents.